Literature DB >> 16880921

Inductive tissue engineering with protein and DNA-releasing scaffolds.

David M Salvay1, Lonnie D Shea.   

Abstract

Cellular differentiation, organization, proliferation and apoptosis are determined by a combination of an intrinsic genetic program, matrix/substrate interactions, and extracellular cues received from the local microenvironment. These molecular cues come in the form of soluble (e.g. cytokines) and insoluble (e.g. ECM proteins) factors, as well as signals from surrounding cells that can promote specific cellular processes leading to tissue formation or regeneration. Recent developments in the field of tissue engineering have employed biomaterials to present these cues, providing powerful tools to investigate the cellular processes involved in tissue development, or to devise therapeutic strategies based on cell replacement or tissue regeneration. These inductive scaffolds utilize natural and/or synthetic biomaterials fabricated into three-dimensional structures. This review summarizes the use of scaffolds in the dual role of structural support for cell growth and vehicle for controlled release of tissue inductive factors, or DNA encoding for these factors. The confluence of molecular and cell biology, materials science and engineering provides the tools to create controllable microenvironments that mimic natural developmental processes and direct tissue formation for experimental and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16880921      PMCID: PMC2657198          DOI: 10.1039/b514174p

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  178 in total

Review 1.  Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices.

Authors:  W L Murphy; D J Mooney
Journal:  J Periodontal Res       Date:  1999-10       Impact factor: 4.419

2.  Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.

Authors:  Y Hu; J O Hollinger; K G Marra
Journal:  J Drug Target       Date:  2001       Impact factor: 5.121

3.  Cell culture: biology's new dimension.

Authors:  Alison Abbott
Journal:  Nature       Date:  2003-08-21       Impact factor: 49.962

Review 4.  Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

Authors:  Siu-Fun Wong
Journal:  Clin Ther       Date:  2005-06       Impact factor: 3.393

5.  Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions.

Authors:  I D Dinbergs; L Brown; E R Edelman
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

6.  Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

Authors:  Celina Franco; John Brandberg; Lars Lönn; Björn Andersson; Bengt-Ake Bengtsson; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

7.  Taking cell-matrix adhesions to the third dimension.

Authors:  E Cukierman; R Pankov; D R Stevens; K M Yamada
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

8.  Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.

Authors:  W M Saltzman; M W Mak; M J Mahoney; E T Duenas; J L Cleland
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

9.  Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation.

Authors:  K Prelle; A M Wobus; O Krebs; W F Blum; E Wolf
Journal:  Biochem Biophys Res Commun       Date:  2000-11-02       Impact factor: 3.575

10.  Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.

Authors:  Stewart G Albert; Arshag D Mooradian
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

View more
  15 in total

Review 1.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

2.  Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.

Authors:  Seungjin Shin; Lonnie D Shea
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

Review 3.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

Review 4.  Engineering hydrogels as extracellular matrix mimics.

Authors:  Hikmet Geckil; Feng Xu; Xiaohui Zhang; SangJun Moon; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

5.  Non-viral vector delivery from PEG-hyaluronic acid hydrogels.

Authors:  Julie A Wieland; Tiffany L Houchin-Ray; Lonnie D Shea
Journal:  J Control Release       Date:  2007-05-01       Impact factor: 9.776

6.  Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.

Authors:  Walter Bonani; Antonella Motta; Claudio Migliaresi; Wei Tan
Journal:  Langmuir       Date:  2012-09-14       Impact factor: 3.882

Review 7.  Emerging technologies for assembly of microscale hydrogels.

Authors:  Umut Atakan Gurkan; Savas Tasoglu; Doga Kavaz; Melik C Demirel; Utkan Demirci
Journal:  Adv Healthc Mater       Date:  2012-03       Impact factor: 9.933

Review 8.  Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration.

Authors:  Anuradha Subramanian; Uma Maheswari Krishnan; Swaminathan Sethuraman
Journal:  J Biomed Sci       Date:  2009-11-25       Impact factor: 8.410

9.  Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery.

Authors:  Jeremy Zhang; Atanu Sen; Eunhee Cho; Jeoung Soo Lee; Ken Webb
Journal:  J Tissue Eng Regen Med       Date:  2014-06-01       Impact factor: 3.963

10.  A peptidic hydrogel that may behave as a "Trojan Horse".

Authors:  Nicola Castellucci; Giorgio Sartor; Natalia Calonghi; Carola Parolin; Giuseppe Falini; Claudia Tomasini
Journal:  Beilstein J Org Chem       Date:  2013-02-22       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.